222 related articles for article (PubMed ID: 36281578)
1. Baseline gut microbial profiles are associated with the efficacy of
Hong G; Li Y; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Scand J Gastroenterol; 2023 Apr; 58(4):339-348. PubMed ID: 36281578
[TBL] [Abstract][Full Text] [Related]
2. Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules.
Lv L; Ruan G; Ping Y; Cheng Y; Tian Y; Xiao Z; Zhao X; Chen D; Wei Y
Front Cell Infect Microbiol; 2022; 12():1025889. PubMed ID: 36250045
[TBL] [Abstract][Full Text] [Related]
3. Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Zhu X; Hong G; Li Y; Yang P; Cheng M; Zhang L; Li Y; Ji L; Li G; Chen C; Zhong C; Jin Y; Yang M; Xiong H; Qian W; Ding Z; Ning K; Hou X
Microbiol Spectr; 2021 Dec; 9(3):e0125521. PubMed ID: 34937163
[TBL] [Abstract][Full Text] [Related]
4. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
[TBL] [Abstract][Full Text] [Related]
5. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
6. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
7. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
8. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
[TBL] [Abstract][Full Text] [Related]
9. Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome.
Liu Y; Li W; Yang H; Zhang X; Wang W; Jia S; Xiang B; Wang Y; Miao L; Zhang H; Wang L; Wang Y; Song J; Sun Y; Chai L; Tian X
Front Cell Infect Microbiol; 2021; 11():645951. PubMed ID: 34178718
[TBL] [Abstract][Full Text] [Related]
10. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
11. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
12. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
Nilholm C; Manoharan L; Roth B; D'Amato M; Ohlsson B
United European Gastroenterol J; 2022 May; 10(4):363-375. PubMed ID: 35484927
[TBL] [Abstract][Full Text] [Related]
13. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
[TBL] [Abstract][Full Text] [Related]
14. Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort.
Brunkwall L; Ericson U; Nilsson PM; Orho-Melander M; Ohlsson B
J Gastroenterol Hepatol; 2021 Jan; 36(1):174-180. PubMed ID: 32428346
[TBL] [Abstract][Full Text] [Related]
15. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.
Hod K; Dekel R; Aviv Cohen N; Sperber A; Ron Y; Boaz M; Berliner S; Maharshak N
Neurogastroenterol Motil; 2018 Dec; 30(12):e13456. PubMed ID: 30136337
[TBL] [Abstract][Full Text] [Related]
16. [Effect of
Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].
Zhu SW; Liu ZJ; Li M; Zhu HQ; Duan LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):231-238. PubMed ID: 29643520
[TBL] [Abstract][Full Text] [Related]
18. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
[TBL] [Abstract][Full Text] [Related]
19. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
Choo C; Mahurkar-Joshi S; Dong TS; Lenhart A; Lagishetty V; Jacobs JP; Labus JS; Jaffe N; Mayer EA; Chang L
Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G134-G143. PubMed ID: 35726867
[TBL] [Abstract][Full Text] [Related]
20. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
